How nattokinase works?

In the crowded landscape of cardiovascular supplements, few ingredients have generated as much genuine scientific excitement as nattokinase - a powerful proteolytic enzyme derived from natto, a traditional Japanese fermented soybean food with over 1,000 years of culinary and medicinal history.

What makes nattokinase extraordinary is not just its traditional pedigree, but the remarkable precision of its biological activity. While most cardiovascular supplements work indirectly - reducing inflammation, improving lipid profiles, or supporting endothelial function - nattokinase works with striking directness: it dissolves blood clots. It targets fibrin - the protein scaffold of dangerous blood clots - and breaks it down with an efficiency that has captivated researchers, cardiologists, and supplement formulators worldwide.

But how exactly does nattokinase work? What are its mechanisms at the molecular level? What does the clinical evidence show? And how should supplement brands source and formulate nattokinase powder for maximum efficacy and market impact?

This comprehensive, science-backed guide answers every critical question about nattokinase - from its enzymatic mechanisms and clinical applications to safety considerations, dosage guidance, and formulation best practices. Let's start with the science.

1. What Is Nattokinase? Origins and Identity

From Ancient Japanese Kitchen to Modern Supplement Science

Nattokinase is a serine protease enzyme produced by the bacterium Bacillus subtilis natto during the fermentation of soybeans into natto - a traditional Japanese food characterized by its distinctive sticky texture, pungent aroma, and extraordinary health properties.

The discovery of nattokinase as a distinct bioactive compound is credited to Dr. Hiroyuki Sumi of the Chicago University Medical School, who in 1980 observed that natto extract could dissolve fibrin clots on a petri dish - a finding that launched decades of scientific investigation into this remarkable enzyme. Dr. Sumi reportedly nicknamed it "nattokinase" - combining "natto" with "kinase" (an enzyme that catalyzes reactions) - though technically it functions as a protease rather than a kinase. (Frontiers in Research)

What Is Nattokinase Powder?

Nattokinase is the concentrated, purified, and standardized form of the nattokinase enzyme, produced through controlled fermentation of Bacillus subtilis natto on soybean substrate, followed by extraction, purification, and spray-drying into a stable powder format.

Key characteristics of commercial nattokinase:

* Activity measurement: Expressed in Fibrinolytic Units (FU) or Nattokinase Units (NKU) - standardized measures of enzymatic fibrinolytic activity per gram

* Typical activity: 2,000–20,000 FU/g depending on concentration and grade

* Appearance: Off-white to pale yellow fine powder

* Stability: Stable under proper storage conditions (cool, dry, protected from moisture)

* Formulation compatibility: Capsules, tablets, enteric-coated formulations

Why enteric coating matters: Nattokinase is a protein enzyme that can be partially degraded by stomach acid. Enteric-coated capsules or tablets protect the enzyme through the acidic stomach environment, releasing it in the more neutral small intestine where absorption is optimal. (Toku Health)

2. How Nattokinase Works: The Complete Mechanistic Picture

This is the core of what makes nattokinase scientifically fascinating - and what every supplement formulator, healthcare practitioner, and health consumer needs to understand. Nattokinase does not work through a single mechanism; it operates through multiple complementary pathways that collectively produce a powerful, multidimensional cardiovascular effect.

2.1 The Fibrin Story: Understanding Blood Clots First

To understand how nattokinase works, you first need to understand what it's working on - fibrin and the blood clotting cascade.

Normal blood clotting (hemostasis): When a blood vessel is injured, the body initiates a carefully orchestrated clotting cascade:

1.Platelets aggregate at the injury site

2.The coagulation cascade activates thrombin

3.Thrombin converts soluble fibrinogen into insoluble fibrin

4.Fibrin forms a mesh-like scaffold that traps red blood cells and platelets

5.The resulting clot seals the wound and stops bleeding

This is healthy, life-saving clotting. The problem arises when clots form inside blood vessels - not in response to injury, but due to atherosclerosis, inflammation, sluggish blood flow, or hypercoagulable states. These pathological thrombi can block coronary arteries (causing heart attacks), cerebral arteries (causing strokes), or pulmonary arteries (causing pulmonary embolism). (Toku Health)

The fibrinolysis system: The body has its own clot-dissolving system - fibrinolysis - centered on the enzyme plasmin, which breaks down fibrin. The primary activator of plasmin is tissue plasminogen activator (t-PA), released by endothelial cells. When this system is overwhelmed or impaired - as it often is in aging, metabolic disease, and chronic inflammation - dangerous clots persist and accumulate.

This is precisely where nattokinase intervenes. (ResearchGate)

2.2 Mechanism 1: Direct Fibrin Hydrolysis - The Primary Action

Nattokinase's most fundamental and powerful mechanism is direct fibrinolysis - the direct enzymatic degradation of fibrin.

As a serine protease, nattokinase cleaves specific peptide bonds within the fibrin mesh, breaking down the structural scaffold of blood clots into soluble degradation products that are safely cleared by the body. This direct fibrinolytic activity is:

* Highly potent - nattokinase demonstrates fibrinolytic activity approximately 4 times stronger than plasmin (the body's own clot-dissolving enzyme) in laboratory comparisons

* Broad-spectrum - nattokinase can degrade both fresh (soft) and older (cross-linked) fibrin clots

* Systemic - after oral absorption, nattokinase circulates in the bloodstream where it can reach clots throughout the vascular system

Research published in PMC confirmed that nattokinase "directly hydrolyzes fibrin clots" as its primary mechanism - the foundational action from which many of its cardiovascular benefits derive. (PMC, 2025)

2.3 Mechanism 2: Plasminogen Activation - Amplifying the Body's Own System

Beyond direct fibrin degradation, nattokinase powerfully amplifies the body's endogenous fibrinolytic system through a second mechanism:

Nattokinase converts prourokinase (the inactive precursor of urokinase plasminogen activator) into its active form - urokinase. Urokinase then converts plasminogen into plasmin - the body's primary fibrinolytic enzyme.

This creates a powerful amplification cascade:

Nattokinase→Prourokinase→Urokinase→Plasminogen→Plasmin→Fibrin degradationNattokinase→Prourokinase→Urokinase→Plasminogen→Plasmin→Fibrin degradation

By activating this endogenous pathway, nattokinase doesn't just dissolve clots directly - it supercharges the body's own clot-dissolving machinery, creating a synergistic fibrinolytic effect that is greater than either mechanism alone. (ResearchGate)

2.4 Mechanism 3: t-PA Upregulation - Enhancing Endothelial Function

Nattokinase has been shown to increase the production and release of tissue plasminogen activator (t-PA) from vascular endothelial cells - the cells lining blood vessel walls.

t-PA is the body's primary physiological activator of fibrinolysis. By upregulating t-PA production, nattokinase enhances the endothelium's natural capacity to prevent and dissolve pathological clots - essentially improving the cardiovascular system's built-in protective mechanisms.

This mechanism is particularly significant because reduced t-PA activity is a well-recognized risk factor for cardiovascular disease - and nattokinase directly addresses this deficiency. (Frontiers in Research)

2.5 Mechanism 4: PAI-1 Inhibition - Removing the Brake on Fibrinolysis

Plasminogen activator inhibitor-1 (PAI-1) is the primary inhibitor of fibrinolysis - it blocks t-PA and urokinase, preventing them from activating plasmin and dissolving clots. Elevated PAI-1 levels are strongly associated with increased cardiovascular risk, deep vein thrombosis, and poor outcomes after heart attack.

Nattokinase has demonstrated the ability to inhibit PAI-1 - effectively removing the molecular "brake" that suppresses the body's fibrinolytic system. By simultaneously upregulating t-PA (the accelerator) and inhibiting PAI-1 (the brake), nattokinase produces a powerful net enhancement of fibrinolytic capacity. (PMC) (ResearchGate)

2.6 Mechanism 5: Antiplatelet Activity - Preventing Clot Formation

Beyond dissolving existing clots, nattokinase also inhibits platelet aggregation - the initial step in thrombus formation. By reducing the tendency of platelets to clump together at sites of vascular injury or atherosclerotic plaque, nattokinase helps prevent new clots from forming in the first place.

This antiplatelet mechanism complements nattokinase's fibrinolytic activity beautifully: it prevents clot formation and dissolves existing clots - a dual-action antithrombotic profile that is genuinely impressive for a natural enzyme. (Frontiers in Research)

2.7 Mechanism 6: Lipid-Lowering Activity - A Newly Recognized Benefit

A 2025 review published in PMC specifically examining nattokinase's role in reducing blood lipids revealed an important and relatively recently characterized mechanism: nattokinase demonstrates significant lipid-lowering activity through multiple pathways:

* Inhibition of HMG-CoA reductase - the same enzyme targeted by statin drugs - reducing cholesterol synthesis in the liver

* Upregulation of LDL receptor expression - enhancing hepatic clearance of LDL cholesterol from the bloodstream

* Reduction of VLDL secretion - lowering triglyceride-rich lipoprotein production

* Anti-inflammatory effects on lipid metabolism - reducing oxidative modification of LDL

This lipid-lowering dimension significantly expands nattokinase's cardiovascular relevance beyond pure antithrombotic activity - positioning it as a genuinely multi-mechanism cardiovascular ingredient. (PMC, 2025)

The Complete Mechanism Summary

3. Clinical Evidence: What the Research Shows

3.1 Blood Pressure Reduction

One of the most clinically significant and well-documented benefits of nattokinase supplementation is blood pressure reduction - an effect supported by multiple human clinical trials.

A landmark randomized, double-blind, placebo-controlled clinical trial published in Hypertension Research (2008) enrolled 86 participants with pre-hypertension or stage 1 hypertension and supplemented them with nattokinase (2,000 FU/day) for 8 weeks. Results showed:

* Systolic blood pressure reduced by 5.55 mmHg compared to placebo

* Diastolic blood pressure reduced by 2.84 mmHg compared to placebo

* Effects were most pronounced in participants with higher baseline blood pressure

The proposed mechanism for blood pressure reduction involves nattokinase's degradation of angiotensin I - a precursor to the potent vasoconstrictor angiotensin II - effectively reducing the renin-angiotensin system's vasoconstrictive activity. (Frontiers in Research)

3.2 Atherosclerosis and Plaque Reduction

A compelling clinical study published in Scientific Reports examined nattokinase supplementation in patients with carotid artery atherosclerosis - directly measuring arterial plaque using ultrasound. Over 26 weeks:

* Nattokinase supplementation significantly reduced carotid plaque size compared to statin therapy alone

* The combination of nattokinase + statin produced greater plaque reduction than either alone

* Nattokinase demonstrated measurable anti-atherosclerotic activity in a human clinical setting - not just in animal models

This is one of the most clinically meaningful findings in nattokinase research - demonstrating actual plaque reduction in human arteries, not just biomarker improvements. (Toku Health, citing Scientific Reports)

3.3 Deep Vein Thrombosis (DVT) Prevention

A randomized controlled trial specifically examining nattokinase for DVT prevention during long-haul air travel - a high-risk scenario for venous thromboembolism - found that nattokinase supplementation significantly reduced:

* Incidence of deep vein thrombosis

* Edema and leg swelling

* Superficial vein thrombosis

This trial is particularly relevant given the global prevalence of long-distance air travel and the well-recognized risk of "economy class syndrome." (Frontiers in Research)

3.4 Lipid Profile Improvement

The 2025 PMC review on nattokinase and blood lipids synthesized evidence from multiple studies demonstrating:

* Significant reductions in total cholesterol (average 10–15% reduction)

* LDL cholesterol reduction (average 8–12% reduction)

* Triglyceride reduction in hyperlipidemic subjects

* Modest HDL elevation in some studies

These lipid-lowering effects, combined with nattokinase's direct antithrombotic mechanisms, create a comprehensive cardiovascular risk reduction profile that addresses multiple independent risk factors simultaneously. (PMC, 2025)

3.5 COVID-19 and Post-COVID Applications: Emerging Evidence

One of the most significant recent developments in nattokinase research involves its potential role in addressing COVID-19-related coagulopathy and post-COVID syndrome ("long COVID"). COVID-19 is characterized by a hypercoagulable state - excessive clot formation in the microvasculature - and many long COVID symptoms are attributed to persistent microclots and impaired fibrinolysis.

Research published in Frontiers and multiple preprint studies have explored nattokinase's ability to:

* Degrade the spike protein of SARS-CoV-2 (in vitro evidence)

* Dissolve COVID-associated microclots

* Restore impaired fibrinolytic activity in post-COVID patients

* Reduce persistent inflammatory markers in long COVID

While this research is still emerging and requires larger clinical trials, it has generated significant scientific and public interest - and has been a major driver of nattokinase market growth in 2023–2025. (Frontiers in Research)

4. Nattokinase vs. Pharmaceutical Thrombolytics: Understanding the Difference

A common question is how nattokinase compares to pharmaceutical thrombolytic drugs (tPA, streptokinase, urokinase) used in emergency medicine for heart attacks and strokes.

The key distinction: Nattokinase is a preventive and maintenance cardiovascular ingredient - not an emergency treatment. It is not appropriate for acute heart attack or stroke management, where pharmaceutical thrombolytics are required. Its value lies in long-term cardiovascular risk reduction through sustained fibrinolytic support, blood pressure management, and lipid improvement. (ResearchGate) (Toku Health)

5. Nattokinase Powder: Bioavailability and Absorption

A critical question for supplement formulators is: does nattokinase survive oral ingestion and reach the bloodstream in active form?

For many years, this was debated - the conventional wisdom being that protein enzymes are degraded by stomach acid and digestive proteases before absorption. However, multiple studies have now confirmed that nattokinase is absorbed orally and reaches systemic circulation in biologically active form:

* A human pharmacokinetic study demonstrated measurable increases in plasma fibrinolytic activity following oral nattokinase administration

* Nattokinase activity was detectable in blood for up to 8–12 hours after a single oral dose

* Enteric-coated formulations significantly improve bioavailability by protecting the enzyme from gastric acid degradation (Frontiers in Research)

Absorption mechanisms: Nattokinase appears to be absorbed via multiple pathways:

* Transcytosis through intestinal epithelial cells

* Paracellular transport through tight junctions

* Lymphatic absorption - bypassing first-pass hepatic metabolism

The oral bioavailability of nattokinase, while not 100%, is sufficient to produce measurable systemic fibrinolytic effects - as confirmed by multiple clinical trials demonstrating blood pressure reduction, improved fibrinolytic markers, and plaque reduction after oral supplementation. (PMC)

6. Health Benefits Beyond Cardiovascular: The Full Spectrum

While nattokinase's cardiovascular applications are its primary claim to fame, research is revealing a broader spectrum of health benefits:

6.1 Alzheimer's Disease and Cognitive Health 

One of the most intriguing emerging applications of nattokinase is neuroprotection and Alzheimer's disease prevention. Research has demonstrated that nattokinase can degrade amyloid fibrils - the abnormal protein aggregates that form amyloid plaques in the brains of Alzheimer's patients.

A study published in Scientific Reports found that nattokinase degraded amyloid fibrils in vitro and in animal models - raising the possibility that nattokinase supplementation might help prevent or slow the progression of Alzheimer's disease. This is a highly active area of ongoing research. (Toku Health)

6.2 Hypertension Management 

Beyond its fibrinolytic activity, nattokinase's ACE-inhibitory properties (inhibition of angiotensin-converting enzyme) contribute to blood pressure reduction through a mechanism similar to pharmaceutical ACE inhibitor drugs - but with a natural, food-derived origin and a much more favorable side effect profile. (PMC)

6.3 Sinusitis and Nasal Polyps 

An unexpected but clinically studied application of nattokinase is the treatment of chronic sinusitis and nasal polyps. The fibrinolytic and anti-inflammatory properties of nattokinase have been shown to reduce nasal polyp size and improve sinusitis symptoms - an application that opens interesting formulation opportunities in the ENT health space. (Frontiers in Research)

6.4 Peripheral Artery Disease (PAD) 

Nattokinase's ability to dissolve fibrin clots and improve blood flow makes it potentially valuable for peripheral artery disease - a condition characterized by reduced blood flow to the limbs due to arterial narrowing and clot formation. Preliminary research supports improved circulation and reduced symptoms with nattokinase supplementation. (ResearchGate)

6.5 Fibromyalgia and Chronic Pain 

Some research suggests that nattokinase's fibrinolytic activity may help address fibrin deposits in muscle tissue that some researchers associate with fibromyalgia and chronic pain conditions - though this application requires more clinical investigation. (Toku Health)

7. Nattokinase Powder in the Supplement Market: Strategic Opportunities

7.1 Market Context

The global nattokinase supplement market is experiencing exceptional growth:

* Driven by rising cardiovascular disease burden globally

* Accelerated by COVID-19-related awareness of coagulation and clotting risks

* Growing consumer preference for natural, food-derived cardiovascular ingredients

* Increasing recognition among integrative medicine practitioners

* Expanding research base supporting new applications (cognitive health, metabolic health)

For supplement brands, nattokinase offers a compelling combination of:

✅ Unique, differentiated mechanism of action (direct fibrinolysis)

✅ Strong and growing clinical evidence base

✅ Consumer-friendly story (derived from traditional Japanese fermented food)

✅ Multiple cardiovascular applications in a single ingredient

✅ Excellent compatibility with complementary cardiovascular ingredients

7.2 High-Opportunity Product Concepts

7.3 Synergistic Ingredient Pairings

Nattokinase's cardiovascular benefits are amplified by several well-researched co-ingredients:

* Serrapeptase - complementary proteolytic enzyme with anti-inflammatory and fibrinolytic activity

* Bromelain - pineapple-derived protease with antiplatelet and anti-inflammatory effects

* Rutin - flavonoid with antiplatelet and vascular protective activity

* CoQ10 - mitochondrial cardiovascular support; complementary mechanisms

* Vitamin K2 (MK-7) - directs calcium away from arteries; synergistic arterial health

* Omega-3 fatty acids - complementary antiplatelet and anti-inflammatory activity

* Magnesium - vascular smooth muscle relaxation; blood pressure support

* Quercetin - anti-inflammatory flavonoid with complementary vascular protection

8. Sourcing Premium Nattokinase Powder: What Buyers Must Know

8.1 Activity Standardization: The Critical Quality Parameter

Unlike most botanical extracts standardized by chemical content (e.g., "95% rutin"), nattokinase quality is defined by its enzymatic activity - measured in Fibrinolytic Units (FU) per gram.

Common commercial grades:

* 2,000 FU/g - standard grade for general cardiovascular support

* 5,000 FU/g - enhanced potency for targeted cardiovascular formulations

* 10,000–20,000 FU/g - high-potency grade for premium formulations

Why activity matters: Two nattokinase powders with the same weight but different FU values will have dramatically different clinical effects. Always specify and verify FU activity when sourcing nattokinase - not just weight per capsule. (Toku Health)

8.2 Vitamin K2 Content: A Critical Safety Consideration

Traditional natto contains significant amounts of Vitamin K2 (MK-7) - a nutrient with important cardiovascular benefits but also significant interactions with warfarin (Coumadin) anticoagulant therapy.

For supplement applications, particularly for consumers on anticoagulant medications, Vitamin K2-free nattokinase is essential. Reputable suppliers offer nattokinase with verified minimal or zero Vitamin K2 content - a critical specification to confirm when sourcing. (Frontiers in Research)

8.3 Essential Certifications

8.4 Soy Allergen Disclosure

Nattokinase is derived from fermented soybeans - making soy allergen disclosure a mandatory regulatory requirement in most markets (USA, EU, Canada, Australia). While the fermentation process significantly reduces soy protein content, allergen testing and appropriate label disclosure are non-negotiable for regulatory compliance. (PMC)

9. Safety Profile, Dosage, and Important Precautions

Is Nattokinase Powder Safe?

Nattokinase has a favorable safety profile supported by its long history of dietary consumption in Japan (where natto is eaten regularly) and a growing body of clinical safety data. It is well-tolerated at typical supplement doses, with no serious adverse events reported in clinical trials at recommended doses. (Frontiers in Research)

Evidence-Based Dosage Ranges

Critical Drug Interactions and Contraindications

Anticoagulant medications (HIGHEST PRIORITY WARNING): Nattokinase's fibrinolytic and antiplatelet activity can significantly potentiate the effects of anticoagulant and antiplatelet medications - including warfarin, heparin, aspirin, clopidogrel (Plavix), rivaroxaban (Xarelto), and apixaban (Eliquis). This combination can increase bleeding risk substantially. Individuals on any blood-thinning medication must consult their healthcare provider before using nattokinase. (ResearchGate)

Pre-surgical use:

Nattokinase should be discontinued at least 2 weeks before any surgical procedure due to its antiplatelet and fibrinolytic activity - similar to the precautions applied to aspirin and fish oil. (Toku Health)

Bleeding disorders:

Individuals with hemophilia or other bleeding disorders should avoid nattokinase supplementation.

Pregnancy:

Insufficient clinical safety data; caution is advised during pregnancy.

10. Frequently Asked Questions About Nattokinase Powder

Q: How long does nattokinase take to work? Blood fibrinolytic activity increases within hours of a single dose, with measurable effects on fibrinolytic markers detectable within 2–4 hours. For sustained benefits like blood pressure reduction and plaque regression, consistent supplementation over 4–12 weeks is typically required. (Toku Health)

Q: Should nattokinase be taken on an empty stomach or with food? Research suggests nattokinase is best absorbed on an empty stomach or between meals - away from food that might dilute its concentration or compete for absorption. However, enteric-coated formulations are less sensitive to timing. (Frontiers in Research)

Q: Can nattokinase replace aspirin for cardiovascular protection? Nattokinase should not be used as a direct replacement for aspirin or other prescribed cardiovascular medications without medical supervision. It may serve as a complementary strategy for individuals seeking natural cardiovascular support, but medication changes should always involve a healthcare provider. (PMC)

Q: Is nattokinase safe for long-term use? Available evidence suggests nattokinase is safe for long-term use at recommended doses. Japanese populations consuming natto regularly throughout their lives - with its high nattokinase content - have among the lowest rates of cardiovascular disease globally, suggesting long-term safety. (ResearchGate)

Q: What is the difference between nattokinase and serrapeptase? Both are proteolytic enzymes with fibrinolytic and anti-inflammatory activity, but they differ in origin (nattokinase from Bacillus subtilis natto; serrapeptase from Serratia marcescens bacteria), substrate specificity, and clinical evidence base. They are often combined in cardiovascular enzyme formulations for complementary effects. (Frontiers in Research)

Conclusion: Nattokinase Powder - Nature's Most Sophisticated Cardiovascular Enzyme

The question "how does nattokinase work?" has a genuinely impressive answer. Through six distinct, complementary mechanisms - direct fibrin hydrolysis, plasminogen activation, t-PA upregulation, PAI-1 inhibition, antiplatelet activity, and lipid-lowering effects - nattokinase delivers a multidimensional cardiovascular benefit profile that is unmatched by virtually any other single natural ingredient.

The clinical evidence is compelling: blood pressure reduction confirmed in randomized controlled trials, carotid plaque regression demonstrated in human studies, DVT prevention validated in travel trials, and lipid-lowering effects documented in multiple studies. And emerging research into COVID-19 coagulopathy, Alzheimer's disease, and chronic sinusitis is continuously expanding nattokinase's therapeutic horizon.

For supplement brands, nattokinase represents one of the most scientifically differentiated, clinically validated, and commercially compelling cardiovascular ingredients available - an enzyme with a 1,000-year traditional pedigree, a growing modern evidence base, and a mechanism of action so unique and powerful that it stands apart from every other natural cardiovascular ingredient on the market.

In a supplement industry often characterized by incremental innovation, nattokinase is genuinely extraordinary - and the science to prove it has never been stronger.

JOYWIN founded in 2013 is an innovation-driven biotechnology company. We provide the manufacture of plant extracts, plant proteases, and customized products. If you want to know more about Nattokinase Powder or are interested in purchasing it, you can send an email to contact@joywinworld.com. We will reply to you as soon as possible after we see the message.